Expanding the limits of cancer therapies


Hemerion develops novel cancer therapies that blend photonics, medecine and biotechnology. Its first breakthrough technology addresses glioblastoma as a complement to neurosurgery. Its efficacy is currently being evaluated in clinical trials.

Nature Journal

Nature highlights the first clinical trials of Hemerion's technologies

Read more

Dr Maximilien Vermandel, Hemerion's founder, presents the news perspectives opened up by Hemerion to treat glioblastomas."


Positive preliminary clinical results for the treatment of glioblastoma developed by Hemerion.

Read the Press Release


We're hiring

Hemerion is looking for a talented regulatory affairs and quality assurance officer.


Hemerion is looking for a clinical trial coordinator.